Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Accumulated Expenses (2023 - 2025)

Camp4 Therapeutics' Other Accumulated Expenses history spans 3 years, with the latest figure at $27000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 84.66% year-over-year to $27000.0; the TTM value through Dec 2025 reached $27000.0, down 84.66%, while the annual FY2025 figure was $27000.0, 84.66% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $27000.0 at Camp4 Therapeutics, down from $176000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $369000.0 in Q3 2024 and bottomed at $27000.0 in Q4 2025.
  • The 3-year median for Other Accumulated Expenses is $232500.0 (2023), against an average of $215250.0.
  • The largest annual shift saw Other Accumulated Expenses tumbled 39.1% in 2024 before it plummeted 84.66% in 2025.
  • A 3-year view of Other Accumulated Expenses shows it stood at $289000.0 in 2023, then crashed by 39.1% to $176000.0 in 2024, then tumbled by 84.66% to $27000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Other Accumulated Expenses are $27000.0 (Q4 2025), $176000.0 (Q4 2024), and $369000.0 (Q3 2024).